Previous studies indicate that Interferon regulatory factor 1 (IRF-1) is crucial in occurrence and evolution of liver diseases, which can inhibit hepatitis virus (A/B/C/E) replication, alleviate liver fibrosis progression, making it a potential mediator for predicting the prognosis and recurrence of liver cancer (120). Here, IRF1 is linked to Hepatic fibrosis.